Table 1.
Baseline demographic and clinical characteristics of the patients according to the incidence of primary outcome events.
| Variables | Event |
P value | |
|---|---|---|---|
| Yes (n = 52) | No (n = 65) | ||
| Age (years) | 54.5 ± 14.8 | 54 ± 14 | NS |
| Body surface area (m2) | 1.81 ± 0.4 | 1.85 ± 0.2 | NS |
| Systolic BP (mmHg) | 120 ± 11 | 123 ± 12 | NS |
| Diastolic BP (mmHg) | 79 ± 4 | 80.3 ± 6 | NS |
| Gender | |||
| Male | 42(80.8%) | 45(69.2%) | NS |
| Female | 10(19.2%) | 20(30.8%) | |
| Etiology of HF | |||
| Ischemic | 24(46.2%) | 26(40%) | NS |
| Non-ischemic | 28(53.8%) | 39(60%) | |
| NYHA class III–IV | 50 (96.2%) | 39(60%) | <0.001 |
| Heart rate | 87 ± 5 | 93 ± 20 | NS |
| Hypertension | 10(19.2%) | 14(21.9%) | NS |
| Smoking | 14(26.9%) | 13(20%) | NS |
| Diabetes | 25(48.1%) | 18(27.7%) | <0.05 |
| Previous myocardial infarction | 19 (36.5%) | 19(29.2% | NS |
| Previous of HF admission | 36(69.2%) | 21(32.3%) | <0.001 |
| Previous PCI | 3(5.8%) | 2(3.1%) | NS |
| Previous CABG | 3(5.8%) | 5(7.7%) | NS |
| B-blockers | 36(69.2%) | 52(80%) | NS |
| ACE-inhibitors | 48(92.3%) | 65(100%) | NS |
| Diuretics | 51(98.1%) | 57(87.7%) | <0.05 |
| Digitalis | 31(59.6%) | 27(41.5%) | <0.05 |
| Spironolactone | 36(69.2%) | 32(49.2%) | <0.05 |
Data are expressed as a mean ± standard deviation or a number (percent). NS = non-significant, BP = blood pressure, HF = heart failure, NYHA = New York heart association, PCI = percutaneous coronary intervention, CABG = coronary artery bypass surgery, ACE = angiotensin converting enzyme.